Appointments
Richard Ridinger, the CEO of Swiss biotechnology firm Lonza Group, will step down from his position in March of this year.
The 60 year old...
Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just...
ImmunSYS, a Fort Lauderdale, Florida-based firm focused on the development of innovative cancer immunotherapy products, today announced that...
AstraZeneca’s Sean Bohen has announced he will step down from his role as chief medical officer at the Anglo-Swedish drugmaker amid speculation...
Roche subsidiary, Foundation Medicine, today announced the appointment of Roche’s senior vice president in global oncology, Cindy Perettie as the...
bluebird bio, a US-based gene therapy biotech with a focus on cancer and severe genetic conditions, has named Nicola Redfern as the new...
The Anglo-Swedish multinational AstraZeneca has named Dr José Baselga as the firm’s new head of research and development in oncology.
The...
Clinical stage biotechnology company Immunocore has announced the appointment of AstraZeneca executive Bahija Jallal as the company’s new CEO....
The Cambridge, Massachusetts pharma firm Ironwood Pharmaceuticals has announced the appointment of AstraZeneca veteran Mark Mallon in preparation...
Liz Barret, the CEO of Swiss firm Novartis Oncology has said that she is standing down after being in the role for less than a year.
The...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
